InvestorsHub Logo
Followers 46
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: marzan post# 289645

Monday, 06/15/2020 2:57:50 PM

Monday, June 15, 2020 2:57:50 PM

Post# of 698855
Small correction Marzan. LL has never said anything about patients in this trial being mesenchymal. It's the 3 yr survivors that have a majority that are free of progression.

You might have meant methylated rather than mesenchymal.
It's true that a great majority of 3yr survivors are meth.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News